authors
- Mamounas, E
- Jeong, J-H
- Wickerham, L
- Smith, R
- Geyer, C
- Ganz, P
- Land, S
- Hutchins, L
- Eisen, Andrea
- Ingle, J
- Costantino, J
- Wolmark, N
Benefit from exemestane (EXE) as extended adjuvant therapy after 5 years of tamoxifen (TAM): intent-to-treat analysis of NSABP B-33.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- 2006
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)